SJS Investment Consulting’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$577 Buy
27
+8
+42% +$150 ﹤0.01% 2223
2026
Q1
$332 Buy
+19
New +$377 ﹤0.01% 1868
2024
Q2
Sell
-1
Closed -$49 1712
2024
Q1
$49 Hold
1
﹤0.01% 1610
2023
Q4
$54 Buy
+1
New +$51 ﹤0.01% 1587
2023
Q3
Sell
-1
Closed -$64 1651
2023
Q2
$64 Buy
+1
New +$64 ﹤0.01% 1546
2023
Q1
Sell
-1
Closed -$53 1628
2022
Q4
$53 Hold
1
﹤0.01% 1538
2022
Q3
$0 Buy
+1
New +$66 ﹤0.01% 1571

Other funds holding USNA

SJS Investment Consulting's USNA Position: Q2 2026 in Review

SJS Investment Consulting increased its Usana Health Sciences (USNA) stake by 42% in Q2 2026, buying an estimated $150 and bringing the position to 27 shares worth $577. The position accounts for ﹤0.01% of the portfolio, ranked #2223.

SJS Investment Consulting first reported a position in USNA in Q3 2022 and has held it in 7 quarters since. 50 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • SJS Investment Consulting held 27 shares of Usana Health Sciences worth $577 as of Q2 2026.
  • SJS Investment Consulting bought 8 Usana Health Sciences shares in Q2 2026, an estimated $150.
  • Usana Health Sciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2223 holding.
  • SJS Investment Consulting first reported a position in Usana Health Sciences in Q3 2022 and has held it in 7 quarters since.
  • 50 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.